Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 301–350 of 631 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07540260	CAIX PET/ CT Guided Radiation Therapy in CcRCC.(COSTAR-002)	recruiting	N/A	70	Peking University First HospitalOTHER	1	Apr 20, 2026	clinicaltrials
NCT07322263	Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC	recruiting	Phase 2	174	Michael A. O'DonnellOTHER	1	Apr 17, 2026	clinicaltrials